U.S. markets close in 6 hours 28 minutes

Cogent Biosciences, Inc. (COGT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
6.310.00 (0.00%)
As of 9:30AM EDT. Market open.
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 7/25/2021
Current
3/31/202112/31/20209/30/20206/30/2020
Market Cap (intraday) 5
248.90M326.57M350.40M99.38M14.33M
Enterprise Value 3
117.56M200.46M364.89M83.28M-9.62M
Trailing P/E
N/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
138.2212.363.983.000.53
Price/Book (mrq)
1.881.39N/A5.190.56
Enterprise Value/Revenue 3
139.96N/AN/A266.92-18.23
Enterprise Value/EBITDA 7
-1.33-15.68-31.90-1.461.35

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-40.47%
S&P500 52-Week Change 335.56%
52 Week High 314.44
52 Week Low 36.01
50-Day Moving Average 37.60
200-Day Moving Average 38.62

Share Statistics

Avg Vol (3 month) 3317.87k
Avg Vol (10 day) 3185.15k
Shares Outstanding 538.41M
Implied Shares Outstanding 6N/A
Float 31.93M
% Held by Insiders 10.56%
% Held by Institutions 1105.35%
Shares Short (Jul 14, 2021) 42.06M
Short Ratio (Jul 14, 2021) 43.93
Short % of Float (Jul 14, 2021) 45.73%
Short % of Shares Outstanding (Jul 14, 2021) 45.35%
Shares Short (prior month Jun 14, 2021) 41.47M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Nov 08, 2020
Ex-Dividend Date 4N/A
Last Split Factor 21:4
Last Split Date 3Nov 08, 2020

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Mar 30, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-4,493.81%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)-62.23%

Income Statement

Revenue (ttm)840k
Revenue Per Share (ttm)0.05
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-15.97M
EBITDA -37.31M
Net Income Avi to Common (ttm)-184.84M
Diluted EPS (ttm)-10.32
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)230.74M
Total Cash Per Share (mrq)6.01
Total Debt (mrq)4.72M
Total Debt/Equity (mrq)2.08
Current Ratio (mrq)28.16
Book Value Per Share (mrq)3.55

Cash Flow Statement

Operating Cash Flow (ttm)-39.32M
Levered Free Cash Flow (ttm)N/A